Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
My friend George Simon, the Medical Director of the Thoracic Oncology Program at the Fox Chase Cancer Institute, is one of the leading experts in clinical research on the molecular correlates of the activity of chemotherapy in patients with lung cancer. We sat down together at the end of the recent World Conference on Lung Cancer to discuss some of this work and the general state of this growing field of research.
Here in audio version of the presentation, a pdf file of the figures, a transcript of our conversation, and the video version with the figures synchronized with the discussion.
[powerpress]
George Simon Audio Interview on Molecular Correlates with Chemo Activity in Lung Cancer
figures-gsimon-on-molecular-correlates-with-chemo-in-nsclc-in-lc
transcript-gsimon-on-molecular-correlates-with-chemo-in-nsclc-in-lc
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…